Surf it.
It gets you where you have to go for lesion access – finding your way through tortuous anatomies. Surfing the coronaries with 16.6% improved trackability** and 12.3% improved pushability**.
No content results match your keyword.
Content
You have successfully logged out.
Not registered yet?
May 19-22, 2026 in Paris, France
Discover the future of coronary drug-coated balloon therapy at EuroPCR 2026. At booth M16, you’ll be among the first to discover SeQuent® Please ASCEND – the benchmark* in coronary DCB performance.
We also invite you to join our sponsored symposia and scientific corner sessions for valuable insights into current challenges, clinical evidence and emerging trends in coronary DCB therapy.
Experience the benchmark in coronary DCB angioplasty: SeQuent® Please’s proven drug coating is now complemented by improved catheter performance to provide enhanced handling in daily interventional practice and deliver evidence-backed DCB treatment.
Building on the trusted heritage of the SeQuent® Please/NEO, the proven crystalline PACCOCATH coating remains at the heart of SeQuent® Please ASCEND.
It gets you where you have to go for lesion access – finding your way through tortuous anatomies. Surfing the coronaries with 16.6% improved trackability** and 12.3% improved pushability**.
When it comes to DCBs, one technology sets the standard: PACCOCATH. Reaching the lesion smoothly helps enable the delivery of our best investigated DCB coating where it is intended to act.
Widely validated, clinically proven and trusted globally. SeQuent® Please ASCEND is documented in 110+ clinical studies and broadly studied across 14 indications / clinical scenarios.
Tuesday, May 19, 2026 | 13:10 to 14:10 | Room 242AB
Topic | Speaker |
Innovations and Insights on Fantom Encore BRS | Gregor Leibundgut |
Recorded Case - Fantom Encore BRS: From Practice to Future | Matthias Lutz |
Recorded Case – The beauty of hybrid approach in PCI with DCB and BRS | Mohd Ali Rosli |
The future is metal-free: Blended DCB & BRS approach for complex lesions | Gregor Leibundgut |
A practical guide to simplify treatment of CTO lesions | Maksymilian Opolski |
Discussion and audience interaction | All |
Thursday, May 21, 2026 | 13:40 to 14:40 | Room 152
Topic | Speaker |
DCB ARC: Setting the standard for DCB PCI | Patrick Serruys |
The beauty of crystalline sirolimus DCB: Clinical Benefits and OCT Insights with SeQuent SCB | Victor Jimenez |
The BASKET BALL Study: Tip-Off to the Future | Raban Jeger |
Real-World Data Matters: 1-Year Clinical Results from the SCORE Registry | Sylvia Otto |
Optimizing STEMI Pathways: Clinical Lessons and Outcomes from the UK STEMI Study | David Hildick-Smith |
Ascending into the future: Introducing the new DCB SeQuent Please ASCEND | Raban Jeger or Victor Jimenez |
Discussion and audience interaction | All |
Tuesday, May 19, 2026 | 18:30 | InterContinental Paris
Join the SeQuent® DCB Cardio Slam, where dynamic clinical DCB case presentations and audience voting will take centre stage.
Known and recognized KOLs in the DCB field: Simon Eccleshall (United Kingdom) | Maksymilian Opolski (Poland) I Tuomas Rissanen (Finland)
InterContinental Paris
Champs‑Élysées Etoile,
64 Av. Marceau, 75008 Paris
Register now to join this inspiring session — either as a Case Presenter or as an attendee eager to learn from real cases and expert discussions. Don’t miss this opportunity to gain valuable insights and be part of the conversation!
Sign upTuesday, May 19, 2026 I 14:30 I Booth M16
Speaker: Simon Eccleshall
Thursday, May 21, 2026 I 14:30 I Booth M16
Speakers: Sylvia Otto, Victor Jimenez
*With the proven PACCOCATH coating unchanged from SeQuent® Please / NEO, the clinical evidence is applicable to SeQuent® Please ASCEND.
**compared to SeQuent® Please NEO
Your feedback matters! Participate in our customer survey to help us enhance our website, products and services. Thank you for your support!